What should you know about neurofilament immunohistochemistry?

A pathologist places thin sections of biopsy tissue on slides and applies antibodies designed to bind to neurofilament proteins. A chemical reaction makes the bound areas visible under a microscope. The pattern, strength and location of staining are considered with the cells’ appearance and other stains. Neurofilament is associated with nerve-cell structures, so the result may support a diagnosis involving neural or neuronal features, but it is not interpreted in isolation.

A positive or negative stain does not by itself name a cancer, determine its stage or predict an individual outcome. The full pathology report may use a panel of markers to separate tumours that look alike. The immunohistochemistry overview explains the broader method.

Usually, no additional procedure is needed for the stain because it uses tissue already collected during a biopsy. Ask whether there is enough tissue for the complete marker panel and whether a specialist review is useful. The final interpretation may be combined with imaging, examination and molecular tests. Keep a copy of the pathology report and ask the clinician to explain unfamiliar terms, including the exact staining pattern and its limits.

The stain itself does not cause symptoms because it is performed on a tissue sample in the laboratory. After the biopsy, seek prompt medical advice for increasing pain, redness, swelling, bleeding, drainage or fever at the sampling site. Urgent care is needed for heavy bleeding, fainting, severe breathing difficulty or rapidly worsening illness.

Ask: Why was neurofilament included in the stain panel? Which cells stained, and what pattern was seen? What other markers were tested? Does the result support a particular tumour type or only add one piece of evidence? Is more tissue, a second pathology opinion or another test needed? When will the complete diagnosis guide treatment planning?